Trials / Unknown
UnknownNCT04503200
Double Guidewire Technique Versus Transpancreatic Precut in Patients With Repetitive Unintentional Cannulation of the Pancreatic Duct.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Difficult cannulation of the common bile duct is encountered in about 10%of ERCP procedures. This frequently happens in the form of repeated unintentional cannulation of the pancreatic duct. Two valid options are available to facilitate cannulation at this point: Double guidewire technique or performing a transpancreatic precut. This is a randomized trial comparing the efficacy and Safety of double guidwire technique versus transpancreatic precut after three unintentional passages of the guidewire into the pancreatic duct.
Conditions
- Endoscopic Retrograde Cholangiopancreatography
- Common Bile Duct Diseases
- Transpancreatic Precut
- Precut
- Double Guidewire
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Double guidewire | After the 3rd passage of the guidewire into the pancreatic duct, the catheter will be removed leaving the guidewire in place. The catheter will be re-inserted and a second guidewire will be used and directed above the pancreatic wire in the 11-12 o'clock direction to attempt cannulation of the common bile duct. |
| PROCEDURE | Transpancreatic precut | After the 3rd passage of the guidewire unintentionally into the pancreatic duct, the guidewire will be left in the pancreatic duct, a sphincterotome will be used to cut in the direction of 11-12 o'clock attempting to deroof the pancreatic duct and gain access into the common bile duct. The wire will then be retracted and reinserted in the direction of the cut to attempt cannulation of the common bile duct. |
Timeline
- Start date
- 2020-08-15
- Primary completion
- 2022-07-31
- Completion
- 2022-08-30
- First posted
- 2020-08-07
- Last updated
- 2020-08-07
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04503200. Inclusion in this directory is not an endorsement.